Aris Economides (Connective Tissue Diseases, Regeneron Pharmaceuticals) presented the unexpected outcome of studies with a selective antibody against ACVR1 in a mouse knock-in model of FOP (Acvr1R206H). Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.